Vaccine Nanotechnology and Uses Thereof
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides vaccine nanocarriers capable of stimulating an immune response in T cells and/or in B cells, in some embodiments, comprising at least one immunomodulatory agent, and optionally comprising at least one targeting moiety and optionally at least one immunostimulatory agent. The invention provides pharmaceutical compositions comprising inventive vaccine nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive vaccine nanocarriers and pharmaceutical compositions thereof. The invention provides methods of prophylaxis and/or treatment of diseases, disorders, and conditions comprising administering at least one inventive vaccine nanocarrier to a subject in need thereof.
Researchers
-
vaccine nanotechnology
United States of America | Granted | 10,736,848 -
vaccine nanotechnology
China | Published application -
vaccine nanotechnology
Israel | Granted | 205,010 -
vaccine nanotechnology
Mexico | Granted | 311,504 -
vaccine nanotechnology
Australia | Granted | 2,008,314,647 -
vaccine nanotechnology
Canada | Granted | 2,702,083 -
vaccine nanotechnology
European Patent Convention | Granted | 2,217,269 -
vaccine nanotechnology
Hong Kong | Published application -
vaccine nanotechnology
United States of America | Granted | 9,539,210 -
vaccine nanotechnology
United States of America | Granted | 9,526,702 -
vaccine nanotechnology
United States of America | Granted | 9,474,717 -
vaccine nanotechnology
European Patent Convention | Granted | 2,630,966 -
vaccine nanotechnology
Australia | Granted | 2,013,206,461 -
vaccine nanotechnology and uses thereof
Mexico | Granted | 350,501 -
vaccine nanotechnology and uses thereof
Hong Kong | Granted | 1,188,925 -
vaccine nanotechnology and uses thereof
Japan | Published application -
vaccine nanotechnology and uses thereof
Japan | Published application -
vaccine nanotechnology and uses thereof
Israel | Granted | 240,444 -
vaccine nanotechnology
Austria | Granted | 2,217,269 -
vaccine nanotechnology
Italy | Granted | 502,017,000,068,248 -
vaccine nanotechnology
Switzerland | Granted | 2,217,269 -
vaccine nanotechnology
Ireland | Granted | 2,217,269 -
vaccine nanotechnology
Austria | Granted | 2,630,966 -
vaccine nanotechnology
Belgium | Granted | 2,630,966 -
vaccine nanotechnology
Switzerland | Granted | 2,630,966 -
vaccine nanotechnology
Germany | Granted | 2,630,966 -
vaccine nanotechnology
Spain | Granted | 2,630,966 -
vaccine nanotechnology
France | Granted | 2,630,966 -
vaccine nanotechnology
Ireland | Granted | 2,630,966 -
vaccine nanotechnology
Italy | Granted | 2,630,966 -
vaccine nanotechnology
United Kingdom | Granted | 2,630,966 -
vaccine nanotechnology
Belgium | Granted | 2,217,269 -
vaccine nanotechnology
Germany | Granted | 2,217,269 -
vaccine nanotechnology
Spain | Granted | 2,217,269 -
vaccine nanotechnology
France | Granted | 2,217,269 -
vaccine nanotechnology
United Kingdom | Granted | 2,217,269 -
vaccine nanotechnology
Israel | Granted | 256,268 -
vaccine nanotechnology
Mexico | Granted | 403,324 -
vaccine nanotechnology
United States of America | Granted | 11,547,667 -
vaccine nanotechnology
Israel | Granted | 269,427
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.